Earlier onset of acute venous thromboembolism with upadacitinib compared with tofacitinib during Janus kinase inhibitor therapy.

Evaluation of smoking status found a nonsignificant trend toward earlier time to VTE formation among former and active smokers compared with never-smokers by log-rank analysis ( P = .30).

also in 5,406 other papers